ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
ATG based conditioning regimen in HLA related allogeneic hematopoietic stem cell
transplantation for aggressive T-cell tumors: multi-center, open, randomized controlled
clinical study
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine